|•||Q1 2014 Press Release:||May 1, 2014 at 7:00 a.m. ET|
|•||Q1 2014 Conference Call:||May 1, 2014 at 8:30 a.m. ET|
|•||Domestic Dial-In Number:||877-407-8037|
|•||International Dial-In Number:||201-689-8037|
|•||Conference ID #||13580001|
The conference call will also be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts.About Incyte Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, please visit the Company's web site at www.incyte.com.